Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSPIRES: Intensive Statin and Antiplatelet Therapy for High-risk Atherosclerosis
NCT03635749Phase 3Unknown
- Sponsor
- Beijing Tiantan Hospital
- Start
- Sep 2018
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of clopidogrel and atorvastatin in ischemic stroke and Transient Ischemic Attack (TIA), sponsored by Beijing Tiantan Hospital. Status: unknown.
02
Drugs
clopidogrelatorvastatin
03
Conditions
ischemic strokeTransient Ischemic Attack (TIA)
Beyond the preview
Go deeper on NCT03635749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03635749.